NDA 020458 · Eton
Galzin
Zinc Acetate · Oral
OrphanLast checked: Nov 19, 2026Latest source record: Apr 25, 2024 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1997
Jan 28, 1997
Approved uses
1
Original approval plus efficacy supplements
Registered trials
414
101 Phase 3, 28 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Jan 28, 1997 Original approval · Type 2 - New Active Ingredient Review
2 products under this application
- GALZIN · ZINC ACETATE EQ 25MG ZINC · CAPSULE, ORAL · Prescription
- GALZIN · ZINC ACETATE EQ 50MG ZINC · CAPSULE, ORAL · Prescription
Clinical trials
Interventional ClinicalTrials.gov studies with "Zinc" as an intervention, any sponsor and status, largest first.
- Impact of Zinc Supplementation on Mortality and Hospitalizations in Children Aged 1 Months to 23 MonthsPivotal-lookingCompleted
Society for Applied StudiesAcademic, hospital or other
NCT00269542 · 94,359 participants · Start Feb 2002 · Primary completion Mar 2003
Drug: Zinc and iron folic acid - Intervention; Iron Folic Acid alone - Placebo · For: Morbidity; Mortality; Diarrhea and 1 more
- Community Trial of Zinc Supplementation on Preschool Child Mortality and Morbidity in Southern NepalPivotal-lookingCompleted
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
NCT00109551 · 58,000 participants · Start Oct 2001
Drug: zinc sulphate dietary supplement; iron sulphate-folic acid dietary supplement · For: Nutrition
Sites: Baltimore, Maryland; Ithaca, New York; Kathmandu and Sarlahi District, Nepal
- Addition of Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care SettingPivotal-lookingCompleted
Society for Applied StudiesAcademic, hospital or other
NCT00278746 · 20,032 participants · Start Jan 2005 · Primary completion Sep 2006
Drug: Zinc and ORS; ORS only · For: Diarrhea; Mortality; Hospitalization
Sites: New Delhi, India
- Evaluate the Efficacy of an Oral Health Behavioral Intervention in People With DiabetesEnrolling by invitation
Colgate PalmoliveIndustry
NCT07619729 · 10,000 participants (planned) · Start May 26, 2026 · Primary completion Jan 2, 2028
Drug: Stannous Fluoride Dentifrice; Cetylpyridinium Chloride (CPC) and Zinc Lactate Mouthwash · For: Diabetes Type 2; Periodontal Disease; Caries
Sites: Long Island City, New York
- Antibiotics for Children With Severe DiarrhoeaPivotal-lookingCompleted
World Health OrganizationAcademic, hospital or other
NCT03130114 · 8,268 participants · Start May 13, 2017 · Primary completion Jan 15, 2020
Drug: Azithromycin · For: Diarrhea
Sites: Dhaka, Bangladesh; New Delhi, India; Nairobi, Kenya · 7 sites in all
- A Preventive Treatment for Migrant Workers at High-risk of COVID-19Pivotal-lookingCompleted
National University Hospital, SingaporeAcademic, hospital or other
NCT04446104 · 4,257 participants · Start May 13, 2020 · Primary completion Aug 31, 2020
Drug: Hydroxychloroquine Sulfate Tablets; Ivermectin 3mg Tab and 2 more · For: Covid-19
Sites: Singapore, Singapore
- Impact of Home Zinc Treatment for Acute Diarrhea in ChildrenPivotal-lookingCompleted
Centers for Disease Control and PreventionFederal agency
NCT00530829 · 3,000 participants · Start Oct 2007 · Primary completion Apr 2009
Drug: zinc · For: Diarrhea
Sites: Kisumu, Kenya
- CHIZAP: Community- and Health Facility-Based Intervention With Zinc as Adjuvant Therapy for Childhood PneumoniaPivotal-lookingCompleted
Centre For International HealthAcademic, hospital or other
NCT00148733 · 2,628 participants · Start Jan 2004 · Primary completion Jan 2008
Drug: Zinc · For: Pneumonia
Sites: Bhaktapur, Nepal
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Zinc supplementation for acute and persistent watery diarrhoea in children: A systematic review and meta-analysis.
Ali AA, Naqvi SK, Hasnain Z, et al. · J Glob Health 2024 · Systematic Review, Meta-Analysis
- Serum zinc levels and efficacy of zinc treatment in acne vulgaris: A systematic review and meta-analysis.
Yee BE, Richards P, Sui JY, et al. · Dermatol Ther 2020 · Meta-Analysis, Systematic Review
- Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis.
Hsu TJ, Hsieh RH, Huang CH, et al. · Nutrients 2024 · Meta-Analysis, Systematic Review
- Zinc supplementation in prediabetes mellitus.
Jayawardena R, Ranasinghe P, Kodithuwakku W, et al. · Minerva Endocrinol (Torino) 2022 · Meta-Analysis, Systematic Review
- Vitamin and Mineral Supplementation During Pregnancy on Maternal, Birth, Child Health and Development Outcomes in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis.
Oh C, Keats EC, Bhutta ZA · Nutrients 2020 · Meta-Analysis, Systematic Review
- Interventions for managing taste disturbances.
Kumbargere Nagraj S, George RP, Shetty N, et al. · Cochrane Database Syst Rev 2017 · Meta-Analysis, Research Support, Non-U.S. Gov't
Sponsor: Eton
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.